5 August 2019

In The News: Dallas Innovates covers PCCI’s involvement with the HHS kidney initiative




Read Dallas Innovates’ coverage of PCCI joining the HHS kidney initiative. Read below:

Parkland Center Joins Kidney Disease Initiative opens in a new window

30 July 2019

PCCI Participating in the HHS ‘Advancing American Kidney Health’ Initiative




DALLAS – Parkland Center for Clinical Innovation (PCCI), which improves healthcare for vulnerable populations using advanced data science and clinical experts, is contributing its capabilities to support elements of the “Advancing American Kidney Health Initiative” announced by the U.S. Department of Health and Human Services (HHS) earlier this month.

The HHS initiative’s aim is to improve the lives of the 37 million patients who suffer from chronic kidney disease and more than 726,000 who have end-stage renal disease. There are nearly 100,000 Americans waiting on the list to receive a kidney transplant. Kidney disease ranks as the ninth leading cause of death in America, costs Medicare $114 billion a year and represents one of the most significant expenses for the VA’s health programs.

PCCI is contributing to the initiative through two grants to the University of Texas Southwestern Medical Center’s Miquel Vazquez, MD. Specifically, PCCI will be applying its proficiency with advanced data science applied to electronic health records to aid at-risk patient identification and develop predictive modeling. This effort is in support of preventing and mitigating kidney disease, keeping patients out of hospitals, and helping find different ways to define and manage kidney disease.

“We are very proud to contribute PCCI’s unique combination of advanced data science and clinical expertise to this important initiative,” said PCCI’s President and CEO, Steve Miff, PhD. “This program, under Dr. Vazquez, the grant principle, is critical to millions of Americans who are suffering from kidney disease. We are excited that PCCI’s experience applying healthcare data in clinical settings with veterans and other groups prone to kidney disease is aiding the kidney health initiative.”

Members of PCCI’s advanced analytics and clinical teams are participating in the initiative’s research studies and work groups, helping advance the program’s goal of transforming the way kidney disease is prevented and treated.

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

23 July 2019

PCCI’s Steve Miff Nominated for Dallas Business Journal’s Most Admired CEO Award




The Dallas Business Journal has announced that PCCI’s CEO, Steve Miff, PhD., has been nominated for its “2019 Most Admired CEO Award” in the healthcare category.

Dr. Miff joined PCCI as president and CEO in January 2017 and leads a pioneering organization that brings together top data scientists and healthcare experts to create programs supporting the health of vulnerable populations.

The Dallas Business Journal’s Most Admired CEO Awards honors the executives who inspire those around them, hold their employees, products and services in the highest regard, run their companies with integrity and are shining examples of how all companies should be run and managed.

Dr. Miff is a recognized national thought leader with more than 20 years of experience in healthcare analytics and consulting. He is a first generation American and has experienced first-hand many of the same challenges as the people PCCI supports in its community.

The Dallas Business Journal will honor its winners at a dinner on September 25, 2019. Rick Allen, CEO of Paragon Healthcare Inc., was the previous winner of the award in the healthcare category.

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

 

17 July 2019

Dallas Medical Journal: Pediatric Asthma Confront the Barriers




PCCI’s mission is to support our community’s vulnerable populations, which includes helping children with chronic health issues, such as pediatric asthma. PCCI has been working for several years opens in a new window developing and testing predictive models to identify children at risk for asthma exacerbations. You can now see how this predictive modeling was used to help support pediatric asthma patients in the July issue of the Dallas Medical Journal opens in a new window.

In an article written by C. Turner Lewis, III, MD, Medical Director of Children’s Medical Clinics of East Texas, Dr. Lewis describes a pediatric asthma pilot program’s success story and the obstacles his team had to overcome. The good news is the children participating in Dr. Lewis’ program, aided by PCCI’s asthma medication ratio data, have experienced positive outcomes.

Have a look at Dr. Lewis’ article here:

Pediatric Asthma

PCCI is proud to be a part of this outstanding program and congratulate Dr. Lewis for the excellent service he is providing to the children of the DFW area.

To learn more about how PCCI’s innovative approach is helping support improved health for vulnerable populations in our communities, please visit our website.

9 July 2019

PCCI’s Aida Somun Named to Malcolm Baldrige National Quality Award Board of Examiners for 2019




DALLAS – The Commerce Department’s National Institute of Standards and Technology (NIST) has named Aida Somun, Chief Operations Officers at Parkland Center for Clinical Innovation (PCCI opens in a new window) in Dallas, Texas, to the Board of Examiners for the 2019 MalcolmBaldrige National Quality Award. The Baldrige Award is the nation’s highest honor for organizational innovation and performance excellence.

Appointed by the NIST Director, examiners are responsible for reviewing and evaluating applications submitted for the Baldrige Award, as well as other assessment-related tasks. The examiner board is composed of more than 325 leading experts competitively selected from industry, professional, trade, education, healthcare and nonprofit (including government) organizations from across the United States.

Those selected meet the highest standards of qualification and peer recognition, demonstrating competencies related to customer focus, communication, ethics, action orientation, team building and analytical skills. All members of the board must take part in a nationally ranked leadership development course based on the Baldrige Excellence Framework and the scoring/evaluation processes for the Baldrige Award. They must also complete an independent review of a Baldrige Award application or other comparable examiner task.

Somun has 15 years of experience as a business leader known for driving profitable growth, cost savings and delivery. She ensures operational excellence through consistent contributions to bottom line efficiency, performance and process improvements. She is most passionate about leading and influencing strategic decision-making for operationalizing the right innovative programs focused on improving individual’s health, both physical as well as socio-economic.

Named after Malcolm Baldrige, the 26th Secretary of Commerce, the Baldrige Award was established by Congress in 1987. Awards may be given annually to organizations in each of six categories: manufacturing, service, small business, education, healthcare and nonprofit. The Award promotes innovation and excellence in organizational performance, recognizes the achievements and results of U.S. organizations, and publicizes successful performance strategies. Since the first group was recognized in 1988, 124 awards have been presented to 115 organizations (including eight repeat recipients).

NIST manages the Baldrige Award in close conjunction with the private sector.

The Baldrige Performance Excellence Program also offers the 2019–2020 BaldrigeExcellence Framework: Proven Leadership and Management Practices for High Performance, which includes the world-emulated Criteria for Performance Excellence;Baldrige Excellence Builder; Baldrige Cybersecurity Excellence Builder; nationally ranked leadership training; and the Baldrige Collaborative Assessment and other assessment tools.

###

 

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI opens in a new window) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI opens in a new window focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI opens in a new window combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

19 June 2019

Parkland Center for Clinical Innovation Expands Opportunities for Women with Data Science and Technology Summer Internship Program




DALLAS – Parkland Center for Clinical Innovation (PCCI), improving healthcare in our communities with advanced analytics and artificial intelligence, recognizes the importance of a STEM education. Offering opportunities to women interested in data science is particularly crucial, which is the mission of PCCI’s summer internship program.

PCCI’s Women in Data Science and Technology Summer Internship, in collaboration with Southern Methodist University’s (SMU) Statistics Department, is one of the most prestigious internship programs in North Texas with a mission to expand opportunities for women in an industry that significantly lacks gender diversity.

The seven women participating in PCCI’s Women in Data Science and Technology Summer Internship program include high school, college and graduate students from Dallas Independent School District high schools, SMU’s Statistics Department as well as students from the University of Texas at Dallas and Creighton University.

The program’s interns will be immersed in PCCI’s daily work where they will directly experience the organization’s innovative healthcare and social determinants of health programs. The students will also have hands-on exposure to the practical applications of analytics, computing and data science.

“The Women in Data Science and Technology Summer Internship program is a rigorous and meaningful path that demonstrates to women what to expect and how to enter the technology market,” Steve Miff, PhD, President and CEO of PCCI. “Because of the important and valuable contributions from organizations such as SMU’s Statistics Department, we are able to place women side-by-side with clinical and data science experts where they can hone their programming and analytics skills within an atmosphere of mentorship and advancement.”

PCCI celebrates diversity and inclusion with a workforce that includes 54 percent women with 30 percent of its employees representing various ethnicities and communities from around the world. As an example of PCCI’s successful commitment to diversity, the Dallas Business Journal recently named Priyanka Kharat, PCCI’s Vice President, Data Engineering and Machine Learning, as a 2019 Women in Technology honoree.

PCCI’s Women in Data Science and Technology Summer Internship program is currently underway and will conclude in mid-August with a presentation program for their PCCI mentors showcasing the impact their projects are having on the Dallas community and Parkland Health & Hospital System.

About Parkland Center for Clinical Innovation

Parkland Center for Clinical Innovation (PCCI) is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

 

###

Parkland Health & Hospital System, Department of Corporate Communications

5200 Harry Hines Blvd., Dallas TX 75235, 469-419-4400

www.parklandhospital.com

27 March 2019

PCCI names new Chief Funding and Innovation Officer




Brings decades of healthcare strategy, innovation management to organization

DALLAS – Leslie Wainwright, PhD has been named Chief Funding and Innovation Officer for the Parkland Center for Clinical Innovation (PCCI).

“We are very excited to welcome Dr. Wainwright to PCCI. Leslie’s experience in working with strategy leaders, innovation executives and philanthropic organizations will be instrumental in PCCI reaching its full potential of advancing artificial intelligence and addressing social determinants of health. Leslie will be integral to the organization as it continues to expand solutions to support healthier communities and a great asset to the PCCI leadership team,” said PCCI’s President and CEO, Steve Miff, PhD.

Dr. Wainwright brings 20 years of experience in healthcare strategy and innovation management to PCCI. She comes from RTI International, a global nonprofit research institution, where she led the Innovation Advisor Health Sector Practice and worked with health systems and technology companies to accelerate the development of high-impact innovations. Through executive roles at Sg2 and AVIA, Dr. Wainwright has worked with some of the largest and most influential organizations in healthcare and has assisted leadership teams structure strategically-aligned innovation programs that are economically self-sustainable. She is a frequent national and international speaker on enabling technologies, disruptive innovation and emerging healthcare business models.

Dr. Wainwright will focus her efforts on expanding PCCI’s innovation research and development network across the Dallas-Fort Worth metroplex and nationally. In addition, she will work with organizations and communities outside of Dallas to accelerate and broaden the impact and development of new and innovative solutions. With deep roots in Chicago and established national relationships she hopes to tap into the same philanthropic and community spirit that has benefitted PCCI and the healthcare community so greatly in Dallas. Dr. Wainwright will divide her time between PCCI’s Dallas office and Chicago.

About PCCI
PCCI is an independent, not-for-profit, healthcare intelligence organization affiliated with Parkland Health & Hospital System. PCCI focuses on creating connected communities through data science and cutting-edge technologies like machine learning. PCCI combines extensive clinical expertise with advanced analytics and artificial intelligence to enable the delivery of patient-centric precision medicine at the point of care.

Contact
PCCI
Esther Olsen
214-590-4446
Esther.olsen@pccinnovation.org

1 October 2018

Parkland RITE program targets prevention of hospital infections and improved sepsis care




Hospital-wide effort reduces infection rates, saves lives

DALLAS —Each year sepsis strikes approximately 1.7 million people in the U.S. and more than a quarter million die from the condition, making it a major cause of death. Healthcare-associated infections (HAI) contribute to about 25 percent of these deaths. According to infection prevention experts, many hospitals are trying different approaches to reduce healthcare-associated infections, improve care of patients presenting with sepsis, and save lives. In 2013, Parkland Health & Hospital System launched an innovative hospital-wide program to reduce HAI and sepsis-related deaths, called RITE (Reduce Infections Together in Everyone).

In the first five years, the multi-disciplinary program has achieved impressive results, reducing rates of infection each year since the program was launched. The net estimated impact of the RITE program is more than a thousand infections prevented and approximately $17,781,000 in cost avoidance.

“Providing quality care begins with providing safe care,” said Parkland’s Chief of Infection Prevention, Pranavi Sreeramoju, MD. “We targeted catheter-associated urinary tract infections and central line-associated blood stream infections hospital-wide, surgical site infections following eighteen different types of surgical procedures, and patients presenting with signs and symptoms of sepsis to our emergency department.”

Parkland’s prevention approach centered on standardizing care of patients at risk for these complications; engaging healthcare personnel by talking to them and exploring barriers to adoption of best practice; standardizing curriculum on how to prevent HAI and improve sepsis care; use of medical informatics tools such as early warning system for sepsis developed by Parkland Center for Clinical Innovation; use of best practice alerts and order sets in the electronic medical records; and improving workflows.

According to Dr. Sreeramoju who is also Associate Professor of Internal Medicine at UT Southwestern Medical Center, Parkland’s RITE initiative forged a new approach to prevention by leaning on one part medical science and two parts social science.

“It’s been said about infection prevention that we know what to do – that’s the medical science. The biggest challenge for hospitals remains getting everyone to do the right thing, all the time,” she said. “Something as basic as hand hygiene requires constant vigilance in a hospital setting. So we decided to focus on identifying the most effective ways to influence behavior and make best practices easier to adhere to.

“We took a ‘high touch’ approach to working with staff, spending time analyzing interactions among multi-disciplinary caregivers, and we gave front-line staff the opportunity to provide input that could help us improve our infection prevention strategies,” Dr. Sreeramoju explained.

The scope of the RITE initiative is massive. Parkland Memorial Hospital has more than 40,000 inpatient discharges and 244,000 emergency department visits annually. Approximately 2,500 patients present to Parkland’s ED with suspected sepsis each year.

During Sepsis Awareness Month in September, organizations like the Sepsis Alliance, one of the nation’s leading sepsis patient advocacy groups, hope to increase public and healthcare professionals’ knowledge about this dangerous and vexing health risk. In a 2016 report, the Sepsis Alliance stated that “even though hospitalizations are increasing, a majority of Americans still don’t know what sepsis is or how to treat it.” The most recent Sepsis Alliance Awareness Survey found that less than one-half of all adult Americans have ever heard of sepsis. And the number is even lower among younger adults.

To learn more about services at Parkland hospital, visit www.parklandhospital.com

Contact

Parkland Health & Hospital System
Catherine Bradley
469-419-4400 catherine.bradley@phhs.org

PCCI
Mike Crouch
214-590-3887 Michael.Crouch@PCCInnovation.org

16 May 2018

PCCI’s Innovation Bridge Opens at Parkland’s Hatcher Station Health Center




Enabling patients to connect to digital technology to better manage their own health

Dallas, TX –The Parkland Center for Clinical Innovation (PCCI) in collaboration with Parkland Health & Hospital System has deployed the Innovation Bridge at the Hatcher Station Health Center. Serving residents of East Dallas, Hatcher Station is one of 12 Community Oriented Primary Care centers (COPCs) operated by Parkland throughout Dallas County. Taking inspiration from the Apple Genius Bar and Ochsner Health System’s O Bar, the Innovation Bridge is designed to bridge the technology divide for patients and caregivers.

Although there are a number of mobile apps in the marketplace that claim to help patients manage a variety of different health conditions, many are not vetted by clinicians or targeted for vulnerable patients. PCCI’s Innovation Bridge was developed by Parkland and PCCI physicians in collaboration with IT experts.

“We are very excited to launch and test the impact of this innovative concept,” said Steve Miff, PhD, President and CEO, Parkland Center for Clinical Innovation. “New technology can be intimidating, so we aim to use a physical space to bridge the technology adoption gap. Linking individuals to relevant digital information is a key step towards personal activation and participation in self-management of health. We are very appreciative for the support and partnership of all our funding partners and our clinical colleagues who helped make this initiative possible.”

(Left to right) James Perez, Dr. Fred Cerise, Steve Miff, Dr. Esmaeil Porsa, Paula Olson, Jessica Hernandez, Stephanie Fenniri, Gretchen Collins, and Vikas Chowdhry at the opening of the PCCI’s Innovation Bridge at Parkland’s Hatcher Station Health Center.

For those not familiar or comfortable with mobile technology available to them, the Innovation Bridge will be staffed by a bilingual Community Technology Liaison who will assist in selection and set up of the right app for each patient’s needs. The person will help guide patients to digital technologies such as MyChart that improve patient engagement, real-time access to personal clinical information, and connections to relevant community resources. An initial list of apps in the following categories has been vetted by PCCI’s team of experts: Asthma, Diabetes, Hypertension, Women’s Health (Pregnancy and Breastfeeding), Mental Health, Pediatric Milestones, Obesity Management, Fitness Tracking and Back Exercises.

“Technology continues to be an essential partner in innovative care delivery at Parkland. As the demand for our services escalates, we are focused on providing the highest possible quality of care to each patient. Innovations like mobile apps empower patients to be full partners with their physicians to assure they receive appropriate medical care and we are pleased to offer the PCCI Innovation Bridge to encourage patients to take advantage of all the resources available to them,” said Fred Cerise, MD, MPH, Parkland’s CEO.

The PCCI Innovation Bridge is located at Parkland’s Hatcher Station Clinic, 4600 Scyene Road, Dallas, 75210. For more information about Parkland, visit www.parklandhospital.com

About PCCI

PCCI is an advanced, nonprofit healthcare analytics R&D organization with a collaborative team of expert data scientists and knowledgeable healthcare professionals that go beyond analyzing a patient’s medical data to provide all-encompassing insights that are revolutionizing healthcare. PCCI is a recipient of more than $50 million in grants directed at developing and deploying patient centric cutting edge technologies connecting communities, Parkland and beyond.

Contact

PCCI
Lindsey Nace, Marketing and Communications
214-590-3887 lindsey.nace@PCCInnovation.org

14 March 2018

PCCI Announces Members of Scientific Advisory Group




PCCI’s Scientific Advisory Group Comprised of National Healthcare Thought Leaders and Experts

Dallas, TX — PCCI announced the formation of a Scientific Advisory Group (SAG) comprised of 12 nationally known thought leaders and experts in healthcare. The SAG will provide strategic guidance for PCCI and its leadership team to identify innovative advances that address market needs. The group will meet several times per year to discuss innovation, industry trends, market dynamics and the political environment in an effort to drive the clinical innovation and economic success of PCCI and its stakeholders.

“The establishment of the PCCI Scientific Advisory Group is an exciting development in our evolution. It is essential for the achievement of our mission to develop answers to the most pressing problems of improving the healthcare status of the communities that we serve in a more cost-effective method,” said Steve Miff, PhD, President and CEO, PCCI. “The next decade will bring unique models that utilize artificial intelligence and advances in care redesign, We want to be at forefront of this transformation.”

The SAG is chaired by one of PCCI’s Executive Advisors, Valinda Rutledge, MBA, and includes:

    • Kimberly Aston, MBA, Executive Advisor, PCCI
    • Richard D. Daniels, EVP and CIO, Kaiser Permanente
    • Richard Humphrey, MBA, CPA, EVP and CFO, Parkland Health & Hospital System
    • Frederick Isasi, JD, MPH, Executive Director, Families USA
    • Keith Kosel, PhD, MHSA, MBA, VP, Strategic Enterprise Relationships, PCCI
    • Rusty Lewis, CIO and Chief Digital Officer, Southside Specialty Pharmacies
    • Rishi Manchanda, MD, MPH, President and Founder, HealthBegins
    • Thomas Maryon, DHA, VP, Clinical Program Operations, Health Care Service Corporation
    • Steve Miff, PhD, President and CEO, PCCI
    • John S. O’Shea, MD, MPA, MS, Senior Fellow, The Heritage Foundation, Center for Health Policy Studies
    • Michael A. Sachs, MSPH, Chairman, TLSG, Inc.


For more information about PCCI’s Scientific Advisory Group, please visit PCCInnovation.org/scientific-advisory-group

About PCCI
PCCI is an advanced, nonprofit healthcare analytics R&D organization with a collaborative team of expert data scientists and knowledgeable healthcare professionals that go beyond analyzing a patient’s medical data to provide all-encompassing insights that are revolutionizing healthcare. PCCI is a recipient of more than $50 million in grants directed at developing and deploying patient centric cutting edge technologies connecting communities, Parkland and beyond.

Contact
PCCI
Lindsey Nace, Marketing and Communications
214-590-3887  lindsey.nace@PCCInnovation.org